145 related articles for article (PubMed ID: 30899388)
1. MicroRNA-613 induces the sensitivity of gastric cancer cells to cisplatin through targeting SOX9 expression.
Xue M; Li G; Sun P; Zhang D; Fang X; Li W
Am J Transl Res; 2019; 11(2):885-894. PubMed ID: 30899388
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
[TBL] [Abstract][Full Text] [Related]
3. Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9.
Sang Q; Liu X; Sun D
Onco Targets Ther; 2018; 11():2429-2438. PubMed ID: 29765228
[TBL] [Abstract][Full Text] [Related]
4. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-4316 inhibits gastric cancer proliferation and migration via directly targeting VEGF-A.
Mousa H; Yuan M; Zhang X; Li X; Shopit A; Almoiliqy M; Alshwmi M; Al-Dherasi A; Xu Y; Zuo Y
Cancer Cell Int; 2020; 20():62. PubMed ID: 32123520
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
[TBL] [Abstract][Full Text] [Related]
8. Promotion of miR-221-5p on the Sensitivity of Gastric Cancer Cells to Cisplatin and Its Effects on Cell Proliferation and Apoptosis by Regulating DDR1.
Jiang X; Jiang M; Guo S; Cai P; Wang W; Li Y
Onco Targets Ther; 2020; 13():2333-2345. PubMed ID: 32256084
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miRNA-105 inhibits the progression of gastric carcinoma by directly targeting SOX9.
Jin M; Zhang GW; Shan CL; Zhang H; Wang ZG; Liu SQ; Wang SQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3779-3789. PubMed ID: 31115004
[TBL] [Abstract][Full Text] [Related]
10. Lactate induces aberration in the miR-30a-DBF4 axis to promote the development of gastric cancer and weakens the sensitivity to 5-Fu.
Wang T; Ji R; Liu G; Ma B; Wang Z; Wang Q
Cancer Cell Int; 2021 Nov; 21(1):602. PubMed ID: 34758839
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1.
Rao M; Zhu Y; Zhou Y; Cong X; Feng L
Am J Cancer Res; 2017; 7(2):323-333. PubMed ID: 28337380
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein.
Wei X; Gao M; Ahmed Y; Gao M; Liu W; Zhang Y; Xie X; Zhao Q; Wang H; Gu K
Oncol Lett; 2019 Aug; 18(2):1607-1616. PubMed ID: 31423228
[TBL] [Abstract][Full Text] [Related]
13. MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN.
Meng L; Chen Z; Jiang Z; Huang T; Hu J; Luo P; Zhang H; Huang M; Huang L; Chen Y; Lu M; Xu AM; Ying S
Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):49-57. PubMed ID: 31828293
[TBL] [Abstract][Full Text] [Related]
14. Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.
Fang Z; Zhang L; Liao Q; Wang Y; Yu F; Feng M; Xiang X; Xiong J
J Exp Clin Cancer Res; 2017 Jan; 36(1):17. PubMed ID: 28114950
[TBL] [Abstract][Full Text] [Related]
15. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
16. MiR-1284 suppresses gastric cancer progression by targeting EIF4A1.
Wei W; Cao W; Zhan Z; Yan L; Xie Y; Xiao Q
Onco Targets Ther; 2019; 12():3965-3976. PubMed ID: 31190893
[No Abstract] [Full Text] [Related]
17. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-25 contributes to cisplatin resistance in gastric cancer cells by inhibiting forkhead box O3a.
He J; Qi H; Chen F; Cao C
Oncol Lett; 2017 Nov; 14(5):6097-6102. PubMed ID: 29113252
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-6852 suppresses cell proliferation and invasion via targeting forkhead box J1 in gastric cancer.
Yu H; Zhang J; Wen Q; Dai Y; Zhang W; Li F; Li J
Exp Ther Med; 2018 Oct; 16(4):3249-3255. PubMed ID: 30214548
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
